Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
New advances in the treatment of acquired severe aplastic anaemia
International Journal of Hematology, 10/07/09
Hows J – The treatment of choice for young patients with an HLA identical sibling remains SCT with the intention of cure. In contrast all new patient with ASAA without a HLA identical sibling donor, those over 35–45 years of age and those with non–severe aplastic anaemia should be treated with IST as first line therapy.
Related Articles
Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
International Journal of Hematology, 10/23/09
Relevance Score: 69%
Aplastic anemia in the orient
International Journal of Hematology, 10/07/09
Relevance Score: 67%
The relationship of aplastic anemia and PNH
International Journal of Hematology, 10/07/09
Relevance Score: 67%
Immunosuppressive Therapy as Frontline Treatment for 33 Children with Acquired Severe Aplastic Anemia
Pediatric Hematology and Oncology, 10/02/09
Relevance Score: 66%
Comparative analysis of G-CSFR and GM-CSFR expressions on CD34+ cells in patients with aplastic anemia and myelodysplastic syndrome
International Journal of Laboratory Hematology, 10/28/09
Relevance Score: 65%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Corticosteroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission
American Journal of Hematology, 12/07/09
Review: erythropoiesis-stimulating agents increase mortality in patients with cancer
Evidence-Based Medicine, 12/07/09
The expanding spectrum of thalassemia intermedia
Hematology, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


